- Home
- Companies
- CeloNova BioSciences, Inc.
- Products
- COBRA - Model SG - Drug-Coated PTCA ...
COBRA - Model SG -Drug-Coated PTCA Balloon
Our proprietary COBRA SG drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery. Developed at a leading, international medical university, the novel coating enables a unique and efficient excipient to carry a non-proliferative drug on the surface of PTCA balloons and has the flexibility to be modified to accommodate a number of clinical applications.
Licensing Opportunities
The COBRA SG drug-coated PTCA balloon is currently being evaluated in animal studies to evaluate effectiveness in treating coronary artery disease and address unmet clinical needs such as small vessel stenosis, restenosis, and bifurcations.
CeloNova is currently looking for interested parties seeking licensing opportunities of this novel technology.
- Small Vessel Stenosis, restenosis and bifurcations
- PTCA Balloons
- Vascular Stents
- Metal/metal oxide (SS, Cobalt-Chromium, Nitinol, Titanium, Magnesium)
- Polymers